Evaluation of skin permeability of drugs by newly prepared polymer membranes

Chemical and Pharmaceutical Bulletin

Volumn 45, Issue 3, 1997, Pages 537-541

  Yamaguchi, Yukiya ^a,b   Usami, Tsutomu ^a   Natsume, Hideshi ^a   Aoyagi, Takao ^c,d   Nagase, Yu ^c   Sugibayashi, Kenji ^a   Morimoto, Yasunori ^a  

^a JOSAI UNIVERSITY   (Japan)

^b ZERIA PHARMACEUTICAL CO LTD   (Japan)

^c SAGAMI CHEMICAL RESEARCH CENTER   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

membrane permeation; skin; skin permeation; synthetic polymer membrane; topical formulation; transdermal drug delivery system

Indexed keywords

INDOMETACIN; POLYMER;

ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; HUMAN; HUMAN TISSUE; HYDROPHILICITY; LIPOPHILICITY; MEMBRANE TRANSPORT; NONHUMAN; SKIN PERMEABILITY; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030967970     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.45.537     Document Type: Article

References (19)

1. Chien Y. W., "Transdermal Controlled Systemic Medications," ed. by Chien Y. W., Marcel Dekker, New York, 1987, pp. 1-22.
2. Guy R. H., Hadgraft J., "Transdermal Drug Delivery," ed. by Guy R. H., Hadgraft J., Marcel Dekker, New York, 1989, pp. 59-81.
3. Skelly J. P., Shah V. P., Maibach H. I., Guy R. H., Wester R. C., Flynn G., Yacobi A., Pharm. Res., 4, 265-267 (1987).
4. Bartek M. J., LaBudde J. A., Maibach H. I., J. Invest. Derm., 58, 114-123 (1972).
5. Barry B. W., J. Controlled Release, 15, 237-248 (1991).
6. Flynn G. L., "Percutaneous Absorption," ed. by Bronaugh R. L., Maibach H. I., Marcel Dekker, New York, 1985, pp. 17-42.
7. Hatanaka T., Inuma M., Sugibayashi K., Morimoto Y., Chem. Pharm. Bull., 38, 3452-3459 (1990).
8. Yamashita F., Yoshioka T., Koyama Y., Okamoto H., Sezaki H., Hashida M., Biol. Pharm. Bull., 16, 690-697 (1993).
9. Potts R. O., Guy R. H., Pharm. Res., 9, 663-669 (1992).
10. Garrett E. R., Chemburke P. B., J. Pharm. Sci., 57, 944-959 (1968).
11. Barry B. W., Brace A. R., J. Pharm. Pharmacol., 29, 397-400 (1977); Barry B. W., El Eini D. I. D., ibid., 28, 219-227 (1976).
12. Barry B. W., Brace A. R., J. Pharm. Pharmacol., 29, 397-400 (1977); Barry B. W., El Eini D. I. D., ibid., 28, 219-227 (1976).
13. Hadgraft J., Ridout G., Int. J. Pharmaceut., 39, 149-156 (1987); 42, 97-104 (1988).
14. Hadgraft J., Ridout G., Int. J. Pharmaceut., 39, 149-156 (1987); 42, 97-104 (1988).
15. Hatanaka T., Inuma M., Sugibayashi K., Morimoto Y., Int. J. Pharmaceut., 79, 21-28 (1992).
16. Okumura M., Sugibayashi K., Ogawa K., Morimoto Y., Chem. Pharm. Bull., 37, 1404-1406 (1989).
17. Yukawa J., Sugibayashi K., Morimoto Y., Yakuzaigaku, 49, 254-262 (1989).
18. Morimoto Y., Hatanaka T., Sugibayashi K., Omiya H., J. Pharm. Pharmacol., 44, 634-639 (1992).
19. Yu C. D., Fox J. L., Ho N. F. H., Higuchi W. I., J. Pharm. Sci., 68, 1347-1357 (1979).